Considering the role of MCP-1 in modulating immune system response together with the relationship between immune abnormalities and schizophrenia, the primary aim of this study was to investigate the potential role of these three single-nucleotide polymorphisms in conferring susceptibility to or protection against schizophrenia. Here, CCL2 is linked to schizophrenia.